arrow_back Back Filing freshness 10-K FY 2023 SEC EDGAR

download Export Data

NP Life Sciences Health Industry Group Inc.

ACAT

— Price unavailable

6 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

NP Life Sciences Health Industry Group Inc. shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth 61.4% ↘

Op. Margin -0.4% ↗

ROIC None

FCF / Share $-0.00 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$164.62K

↑ +61.4% —

Net Income Profit after all expenses

$-2.94K

↑ +84.4% —

Operating Margin Operating profit as % of sales

-0.4%

↑ +97.7% 28th

FCF / Share Free cash flow per share

$-0.00

↓ -178.4% —

Health Breakdown

Profitability ↑

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	61.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1128%)	191.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3730%)	133.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2566%)	-65.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1402%)	—	—
Net Income Growth YoY (%)	84.4% Excellent ↑ Excellent Improving Year-over-year change in net income	71.3% Excellent ↑ Excellent Improving Year-over-year change in net income	49.9% Excellent Excellent Year-over-year change in net income	-20.4% Weak Weak Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	122.2% Excellent Excellent Compound annual revenue growth over 3 years	33.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-0.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-103%)	-18.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-254%)	-187.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1664%)	—	-253.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2210%)	—
Effective Tax Rate (%) (%)	-119.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	-1.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-122%)	-18.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-331%)	-187.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2446%)	—	-253.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3264%)	—
FCF Margin (%) (%)	-44.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	92.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-259.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-9.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	25.08x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-4.98x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.38x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	—	—	-135.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-99.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-36.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-0.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-171.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-110.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-43.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	-172.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1247%)	-126.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-941%)	-46.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-409%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	-1.07x Weak Weak Operating income divided by interest expense Optimal: > 5x	-18855.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-70.61K	$-121.86K	$-27.99K	$-118.61K	$-242.93K	$-200.00

📊 What does each share earn? 6 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.00	—	—	—
Basic EPS, GAAP (USD)	$0.00	$0.00	—	—	—	—
Free Cash Flow per Share (USD)	$-0.00	$0.00	$-0.00	—	—	—
Book Value per Share (USD)	—	—	$0.00	$0.00	$0.01	—
Tangible Book Value per Share (USD)	—	—	$0.00	$0.00	$0.01	—
Basic Weighted Avg Shares (shares)	42.96M	42.96M	42.96M	—	—	—

🏦 How resilient is the balance sheet? 1 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Total Equity (USD)	—	—	$38.17K	$103.85K	$234.91K	$-20.68K

📋 What is driving earnings? 3 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$164.62K	$102.00K	$34.99K	$15.00K	$43.00K	—
Net Income, GAAP (USD)	$-2.94K	$-18.86K	$-65.68K	$-131.06K	$-108.83K	—
Operating Cash Flow (USD)	$-73.61K	$93.87K	$-90.62K	$-124.32K	$-4.27K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 21 quarters

NP Life Sciences Health Industry Group Inc.

Analytical Summary

6-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ACAT with peers